The U.S. District Court for the District of Hawaii denied AstraZeneca’s request to block a state law protecting 340B contract pharmacy arrangements.
In its ruling, issued Feb. 23, the court found that Hawaii’s Act 29 is not preempted by federal law, does not violate the Constitution’s spending clause and does not unlawfully discriminate against federal contractors. The court said AstraZeneca failed to demonstrate a likelihood of success on the merits.
The decision allows Hawaii to continue enforcing its 340B protections while litigation proceeds.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
